Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Strattera
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Strattera 40mg capsules
0404000S0BBABAB
|
Strattera | Atomoxetine hydrochloride | Central Nervous System | 212 |
|
Strattera 25mg capsules
0404000S0BBADAD
|
Strattera | Atomoxetine hydrochloride | Central Nervous System | 171 |
|
Strattera 10mg capsules
0404000S0BBAAAA
|
Strattera | Atomoxetine hydrochloride | Central Nervous System | 135 |
|
Strattera 60mg capsules
0404000S0BBAEAE
|
Strattera | Atomoxetine hydrochloride | Central Nervous System | 123 |
|
Strattera 18mg capsules
0404000S0BBACAC
|
Strattera | Atomoxetine hydrochloride | Central Nervous System | 108 |
|
Strattera 4mg/1ml oral solution
0404000S0BBAHAK
|
Strattera | Atomoxetine hydrochloride | Central Nervous System | 97 |
|
Strattera 80mg capsules
0404000S0BBAFAF
|
Strattera | Atomoxetine hydrochloride | Central Nervous System | 67 |
|
Strattera 100mg capsules
0404000S0BBAGAH
|
Strattera | Atomoxetine hydrochloride | Central Nervous System | 24 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.